Auna (AUNA) Q2 2026 Earnings Call Transcript
Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.
How this was made

The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth, cash generation, and operational challenges, informing short‑term trading decisions.
Market read
Auna's earnings update is the primary catalyst for its stock movement and may influence other Latin American health‑care peers.
What to watch
Potential impact of new tax and labor cost changes in Mexico on future profitability.
Background
Auna operates a regional health‑care platform across Peru, Mexico, and Colombia, recently expanding high‑complexity services.
Ticker impact
Q2 2026 earnings call disclosed 9% revenue growth, margin pressure and adjusted EBITDA decline, providing fresh financial guidance.
Potential modest upside if guidance beats expectations; downside risk if margins remain pressured.
Strong top-line growth offsets EBITDA decline; investors will focus on cash flow and guidance for H2.
Market effects
Highlights growth in Latin American healthcare services and potential for further consolidation.
Positive for Peru, Mexico, and Colombia healthcare markets.
Limited to investors focused on emerging market health stocks.
Counterpoint
Margin pressure and EBITDA decline may signal underlying cost issues despite revenue growth.
Key entities
- ExecutiveSuso Zamora
Executive Chairman and President of Auna
- ExecutiveGisele Remy
Chief Financial Officer of Auna




